Anti-Aging Peptide Stacks: A Practical Guide to the Most Researched Combinations

Anti-aging peptide stacking has become one of the most discussed topics in longevity research. The idea is straightforward: instead of using a single peptide, you combine two or more compounds that each target a different aging pathway — cellular energy, DNA repair, hormone optimisation, or tissue regeneration. Together, they can address the biology of aging from multiple angles at once.

This guide breaks down the most researched anti-aging peptide combinations, explains why each one works the way it does, and helps you understand which approach might align with your goals — whether you are just starting out or looking to build a more comprehensive protocol.

Why Stack Peptides for Anti-Aging?

Aging is not caused by a single thing going wrong. It is the result of multiple biological processes slowly declining at the same time: your mitochondria become less efficient, your telomeres shorten, growth hormone levels drop, collagen production slows, DNA repair becomes less accurate, and your immune system gradually weakens. No single peptide addresses all of these simultaneously.

Stacking allows you to target several of these pathways at once. When the peptides are chosen carefully, they complement each other — one handles cellular energy while another supports collagen, a third protects telomere length, and a fourth restores growth hormone signalling. The result is a protocol that works with the full picture of aging rather than just one piece of it.

Research also suggests that synergy between peptides can allow lower individual doses while maintaining strong results — which can reduce side effect risk and make protocols more sustainable over time.

The Core Hallmarks of Aging — and Which Peptides Target Them

Before diving into specific stacks, it helps to understand what you are actually targeting. Modern aging science identifies several core mechanisms that drive biological aging:

• Telomere shortening — the protective caps on DNA strands shrink with each cell division, eventually triggering cell death or dysfunction
• Mitochondrial decline — cells produce less energy as mitochondria become less efficient with age
• Cellular senescence — damaged cells that stop dividing but don’t die, releasing inflammatory signals that accelerate aging in surrounding tissue
• Loss of proteostasis — the system that manages protein folding and repair degrades, leading to accumulation of damaged proteins
• Hormonal decline — growth hormone, IGF-1, and sex hormones all decline significantly after the age of 30–35
• Chronic low-grade inflammation — sometimes called “inflammaging”, this drives tissue breakdown across the entire body
• Extracellular matrix deterioration — the collagen and structural proteins that hold tissues together break down faster than they are replaced

The most effective anti-aging peptide stacks target at least two or three of these pathways simultaneously.

Stack 1: The Longevity Foundation — Epithalon + GHK-Cu

This is the most widely recommended starting point for anyone building an anti-aging peptide protocol. It pairs two compounds that work through completely different mechanisms and complement each other well.

Epithalon — Telomere Protection

Epithalon is a synthetic tetrapeptide derived from a protein found in the pineal gland. It is one of the most extensively studied peptides in longevity research, with decades of work — primarily from Russian researchers — exploring its effects on telomere length, circadian rhythm regulation, and lifespan extension in animal models.

Its primary mechanism is the activation of telomerase — the enzyme responsible for maintaining telomere length. Telomeres naturally shorten with each cell division, and critically short telomeres trigger cellular senescence or cell death. Epithalon appears to slow this process, and some studies in animal models suggest it can actually restore telomere length in aged tissues.

Beyond telomeres, Epithalon has been studied for its effects on melatonin regulation, circadian rhythm restoration, and antioxidant activity — all of which become increasingly important with age.

Research protocol: 5–10mg daily for 10–20 days, 2–3 times per year. Unlike most peptides, Epithalon is used in short, intensive cycles rather than continuously.

GHK-Cu — Gene Expression and Cellular Repair

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper tripeptide found in human blood plasma. It is perhaps the most comprehensively studied peptide in the anti-aging field, with research showing it modulates the expression of over 4,000 genes — including those governing collagen synthesis, DNA repair, antioxidant response, and anti-inflammatory pathways.

GHK-Cu levels decline significantly with age — dropping by approximately 60% between the ages of 20 and 60. This decline is associated with reduced skin integrity, slower wound healing, increased oxidative stress, and declining cellular repair capacity.

As an injectable, GHK-Cu delivers systemic benefits beyond what topical application can achieve — supporting tissue regeneration, reducing inflammation, and activating repair processes throughout the body.

Research protocol: 1–2mg daily or 5 days per week, for 4–12 week cycles.

Why They Work Together

Epithalon focuses primarily on cellular lifespan — protecting the clock that determines how long cells can keep dividing. GHK-Cu focuses on cellular quality — the repair and regeneration of tissues between divisions. Together they address both the length of the cellular lifespan and the quality of the tissue produced during it. This is the combination most commonly cited as the foundation of a longevity-focused peptide protocol.

Stack 2: The GH Optimisation Stack — CJC-1295 + Ipamorelin−10% →

Growth hormone (GH) declines by approximately 1% per year after the age of 30. By the time most people reach their 50s, they are producing roughly half the GH they did in their 20s. This decline is directly linked to changes in body composition, reduced recovery capacity, declining sleep quality, and a range of age-related metabolic changes.

CJC-1295 and Ipamorelin work through complementary mechanisms to restore natural GH pulsatility — without the side effects associated with synthetic HGH administration.

• CJC-1295 is a GHRH (growth hormone releasing hormone) analogue. It increases the amount of GH released per pulse from the pituitary gland.
• Ipamorelin is a selective GHRP (growth hormone releasing peptide). It increases the frequency of GH pulses without significantly raising cortisol or prolactin — a key advantage over older GHRPs.

Together, research suggests they can produce 3–5 times greater GH release compared to either peptide alone. The most common protocol administers both in the same syringe, 30 minutes before sleep, when the body’s natural GH pulse is largest.

Anti-aging benefits studied: improved body composition, better sleep quality, faster recovery from training, improved skin and hair, elevated IGF-1, and improved bone density markers over longer cycles.

Research protocol: 100–200mcg CJC-1295 + 100–300mcg Ipamorelin in the same syringe, 30 minutes before sleep. 8–16 week cycles with 4 weeks off.

Stack 3: The Mitochondrial Stack — MOTS-C−10% → + SS-31

Mitochondrial function is one of the central drivers of biological aging. As mitochondria become less efficient with age, cells produce less ATP, generate more reactive oxygen species (free radicals), and become increasingly vulnerable to damage. This is directly linked to fatigue, metabolic decline, and the progression of many age-related diseases.

MOTS-C

MOTS-C is a peptide encoded by mitochondrial DNA — one of the very few peptides with this origin. It activates AMPK, the master metabolic switch, improving glucose uptake, fatty acid oxidation, and insulin sensitivity. It has been described as an “exercise mimetic” because it appears to activate many of the same metabolic pathways as physical training.

MOTS-C levels naturally decline with age, and research in animal models has shown that supplementation can improve physical endurance, reduce metabolic dysfunction, and extend healthspan. Early human research shows improvements in insulin sensitivity and energy metabolism.

SS-31

SS-31 (also known as Elamipretide) is a mitochondria-targeted peptide that concentrates specifically in the inner mitochondrial membrane. It protects cardiolipin — a critical structural lipid — from oxidative damage, stabilising the electron transport chain and restoring mitochondrial function. Research has shown it can reverse age-related mitochondrial dysfunction in animal models, improving energy production and reducing oxidative stress.

Community consensus is to run SS-31 first to repair and stabilise mitochondrial function, then follow with MOTS-C to optimise metabolic output. Running them sequentially rather than simultaneously appears to produce better results.

Research protocol: SS-31: 1–2mg daily for 4–6 weeks, then MOTS-C: 5–10mg 3x per week for 8–12 weeks.

Stack 4: The Comprehensive Longevity Protocol

For researchers building a more complete protocol, the most commonly discussed combination in the longevity community combines elements from all three of the above stacks into a structured year-round approach. This is not something to begin all at once — it is built gradually over time, introducing one compound at a time.

Blood work is strongly recommended before starting and every 3 months during the protocol — particularly IGF-1, fasting glucose, and a full metabolic panel.

Emerging Additions: NAD+−10% → and Thymosin Alpha-1

NAD+ Precursors

NAD+ is not a peptide in the traditional sense, but it is closely integrated into anti-aging peptide protocols because of its central role in sirtuin activation, DNA repair, and mitochondrial function. NAD+ declines by approximately 50% between the ages of 20 and 50, and this decline is increasingly identified as a driver of multiple hallmarks of aging. Subcutaneous NAD+ injection or oral precursors (NMN, NR) are often layered alongside peptide protocols for their complementary effects on cellular energy and longevity signalling.

Thymosin Alpha-1

Immune function declines substantially with age — a process called immunosenescence. Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide that activates T-cells and natural killer cells and modulates the immune response. It is clinically approved in over 35 countries for viral infections and as a cancer adjunct therapy. In an anti-aging context, it addresses the immune component of aging — helping maintain the surveillance and repair functions that keep disease at bay as the immune system weakens with age.

How to Think About Building a Stack

The most important principle when building an anti-aging peptide stack is to start simple. The biohacking community’s most experienced members consistently recommend beginning with two compounds, understanding how your body responds, and only then introducing additional elements. Most researchers report the best results with stacks of 2–4 peptides — not because more wouldn’t theoretically help, but because it becomes very difficult to understand what is driving results, or problems, in a more complex protocol.

A sensible starting point for most people:

1. Start with GHK-Cu + CJC-1295/Ipamorelin — covers both tissue repair and GH optimisation, two of the most impactful anti-aging mechanisms, with a well-established safety profile
2. After 2–3 months, assess your response — blood work, subjective wellbeing, sleep quality, recovery
3. Add Epithalon as a short cycle — 10–20 days of daily dosing, 2–3 times per year
4. Later, consider MOTS-C or SS-31 if metabolic function or energy are specific goals

Important Considerations

Anti-aging peptide research is a genuinely exciting field, but it is important to approach it with realistic expectations and appropriate caution. The majority of the most compelling research has been conducted in animal models — human clinical data remains limited for most of these compounds. Most of the protocols described in this article are based on preclinical research, community-derived protocols, and early human observations rather than large-scale randomised controlled trials.

Quality matters enormously. Peptides sold as research compounds vary widely in purity and accuracy of labelling. Always source from suppliers who provide third-party Certificates of Analysis (COA) for every batch.

Medical supervision is strongly recommended for any injectable peptide protocol, particularly for longer-term use. The interactions between multiple peptides are not fully characterised, and individual responses can vary significantly.

This article is for educational and research purposes only. These are research compounds not approved for therapeutic use. It does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.